Advertisement
Advertisement
LCTX
Lineage Cell Therapeutics, Inc.
1.28
USDSponsored
-0.05
-3.76%
May 13, 16:00 UTC -4
Closed
Pre-Market
1.30
+0.02
+1.48%
Lineage Cell Therapeutics, Inc. Financial Snapshot
| Market Cap | 323.84M |
| Beta | 1.79 |
| Earnings Per Share (EPS) | -0.28 |
| Price-to-Book (P/B) Ratio | 7.92 |
| Operating Margin | -247.00% |
| Total Debt/Equity (D/E) | 0.16% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -76.13% |
| Current Ratio | 5.20% |
| Free Cash Flow | -19.44M |
Trending Stocks
Advertisement